{"id":2507,"count":1,"description":"","link":"https:\/\/der-arzneimittelbrief.com\/schlagwort\/elite-i-und-ii-studie","name":"ELITE-I- und -II-Studie","slug":"elite-i-und-ii-studie","taxonomy":"post_tag","meta":[],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags\/2507","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/taxonomies\/post_tag"}],"wp:post_type":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts?tags=2507"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}